Biomedicine is the core industry of the biobased economy and one of the strategic emerging industries with the most active innovation and rapid development in the world. It concerns people's life, health and well-being, and is highly strategic, driving and growing. In order to fully implement a series of major decisions and deployments made by the Central Committee of the Communist Party of China and the State Council on promoting the construction of a healthy China, and further promote the high-quality development of the biopharmaceutical industry in Gansu Province, the Gansu Provincial People's Government has issued the "14th Five Year Plan" for the development of the biopharmaceutical industry in Gansu Province. Lanzhou Ximai International Medical has entered the key development field of high-end medical devices with multiple products.



The "14th Five Year Plan" for the Development of the Biomedical Industry in Gansu Province clearly proposes to promote the research and industrialization of orthopedic implant (insertion) devices such as shape memory alloy human skeletal fixation devices, titanium nickel memory alloy cervical anterior fusion devices, and spinal spreaders, and strengthen the research and application of medical catheters, guide wires, guide sheaths, balloons, coated stents, cardiovascular stents, and their delivery devices Research and industrialization of cardiovascular implant devices such as artificial mechanical heart valves. Lanzhou Ximai International Medical has always adhered to the principle of innovation, actively responded to the government's call, supported the government's medical industry planning, and was selected by the government; Fourteenth Five; Major construction and production projects.



Ximai International Medical Co., Ltd. Lanzhou Ximai International Medical Co., Ltd. has six wholly-owned subsidiaries, three of which are national high-tech enterprises, each with its own; Unique Skills&# quo;, Having a certain say in the industrial chain and establishing a competitive advantage in segmented fields. The artificial mechanical heart valve developed by Lanzhou Lanfei Medical won the second prize of the National Science and Technology Progress Award in 2019, and Lanzhou Ximai Memory Alloy won the first batch of national key specialized, refined, and innovative products in 2021; Little Giant; Enterprise. In 2021, Ximai Medical Memory Alloy Endoscopic Rib Products were listed in The Annals of thoracic surgery Surgery, one of the three major thoracic and cardiovascular surgery magazines in the world, for three consecutive times, marking that Ximai Medical's products have taken the lead in the international professional field of cardiothoracic surgery. Lanzhou Ximai International Medical Co., Ltd. actively responds to the national call and takes the development of innovative medical devices as its foothold. Through the mode of production, learning, and research, it plans to localize high-end devices and make up for the shortcomings of domestic high-end medical devices by utilizing its own advantages. Its products include cardiology, thoracic surgery, orthopaedics, general surgery, gastroenterology, obstetrics and gynecology, urology, neurosurgery and other departments< br />
 < br />